In vivo administration of artificial Antigen Presenting Cells activates low avidity T cells for treatment of cancer

The development of effective anti-tumor immune responses is normally constrained by low avidity, tumor-specific cytotoxic T lymphocytes (CTLs) which are unable to eradicate the tumor. Strategies to rescue anti-tumor activity of low avidity melanoma-specific CTLs in vivo may improve immunotherapy eff...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ugel, Stefano, Zoso, Alessia, De Santo, Carmela, Li, Yu, Marigo, Ilaria, Zanovello, Paola, Scarselli, Elisa, Cipriani, Barbara, Oelke, Mathias, Schneck, Jonathan P., Bronte, Vincenzo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2825113/
https://ncbi.nlm.nih.gov/pubmed/19934317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-0400
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller